The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Athenex, Inc. and its affiliates on May 14, 2023. The affiliates include Athenex Pharmaceuticals LLC, Athenex Pharmaceutical Division, LLC, Athenex R&D LLC, Kuur Therapeutics Inc., Cell Medica, Inc. The cases would be jointly administered for administrative and procedural purposes Athenex, Inc. has been designated as the lead debtor.